Exscientia PLC (EXAI)
4.74
-0.21
(-4.24%)
USD |
NASDAQ |
May 23, 16:00
4.74
0.00 (0.00%)
After-Hours: 20:00
Exscientia Total Assets (Quarterly): 597.86M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 597.86M |
| December 31, 2023 | 650.61M |
| September 30, 2023 | 671.21M |
| June 30, 2023 | 711.30M |
| March 31, 2023 | 747.18M |
| December 31, 2022 | 786.20M |
| September 30, 2022 | 751.20M |
| Date | Value |
|---|---|
| June 30, 2022 | 846.68M |
| March 31, 2022 | 943.76M |
| December 31, 2021 | 864.67M |
| September 30, 2021 | 414.94M |
| June 30, 2021 | 374.29M |
| December 31, 2020 | 105.92M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
105.92M
Minimum
Dec 2020
943.76M
Maximum
Mar 2022
651.22M
Average
711.30M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Akero Therapeutics Inc | 912.24M |
| AstraZeneca PLC | 102.29B |
| Adaptimmune Therapeutics PLC | 258.01M |
| Biodexa Pharmaceuticals Plc | 13.43M |
| Verona Pharma PLC | 289.91M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 180.49M |
| Shareholders Equity (Quarterly) | 302.35M |
| Current Ratio | 6.296 |
| Net Debt Paydown Yield | 0.01% |